4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-004624
Chief Financial Officer sold 81,875 shares at $14.55 ($1,191,281)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2019-01-17 | Sale | −81,875 | $14.55 | $1,191,281 | 305,607 | D: show line 1 in the form |
| Open-market sales · 81,875 sh · avg $14.55 · $1,191,281 | |||||||
Loading xslF345X03/doc4.xml…